Manufacturing and Production

Showing 15 posts of 5872 posts found.

novartis image

Novartis’ Nebraska OTC plant still troubles company

February 11, 2013 Manufacturing and Production Novartis, OTC

Novartis has been forced to recall various over-the-counter (OTC) medicines made at its plant in Lincoln, Nebraska, after discovering failures …

Pharma manufacturing news in brief

February 11, 2013 Manufacturing and Production Almac, MeadWestvaco, Rexam, UPS, lilly

A round-up of pharma manufacturing news, including facility updates from MeadWestvaco, Rexam, Almac, UPS and Kemwell Biopharma. MeadWestvaco has said …
image

Market access: please, no more talk of ‘hurdles’ and ‘obstacles’

February 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing barr, market access, pm society

For the UK pharmaceutical industry, biotech or devices firms, any discussion around market access tends to be synonymous with ‘hurdles’ …
screen_shot_2013-02-05_at_14

Aesica recruits operations director

February 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, CMO

Contract manufacturing organisation (CMO) Aesica has appointed Jarrett Palmer as Operations director of its formulated products business unit business. Palmer …
lennernas_2

Recipharm appoints Hans Lennernäs to operating Board

February 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Recipharm

Recipharm Pharmaceutical Development AB has announced the appointment of Dr Hans Lennernäs to the company’s Board of directors. Lennernäs is …
Shanghai image

SFDA publishes high-risk excipients list

February 5, 2013 Manufacturing and Production China, GMP, SFDA

China’s State Food and Drug Administration (SFDA) has published a list of 28 excipients which are considered high-risk and therefore …
Roche image

Facility of the year: 2013 winners announced

February 4, 2013 Manufacturing and Production Biogen, MedImmune, Merck, Novartis, Roche

Three US and three European manufacturing plants have been selected as category winners for the annual Facility of the Year …

USP rejects appeals on elemental impurities update

February 4, 2013 Manufacturing and Production USP

The US Pharmacopeial Convention (USP) has rejected an appeal by drugmakers and suppliers of pharmaceutical ingredients to postpone publication of …

Pharma manufacturing news in brief

February 4, 2013 Manufacturing and Production ACS, Amcor, Beanne, Iogen Bio-products, Novozymes, Pluristem

Facility investments from Amcor and Pluristem, Beanne Chemical falls foul of FDA inspectors, Novozymes acquisition plus a green chemistry app.
dalton

NHS Commissioning Board executive departs

February 4, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, Dalton, NHS

The NHS Commissioning Board has announced the forthcoming departure of its chief operating officer and deputy chief executive. Ian Dalton …
andrew_ajello_-large

Novo Nordisk creates four senior vice presidents

February 1, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk

Novo Nordisk has promoted four corporate vice presidents within its ranks into senior vice presidents.  The following members of the US …
EMA offices, London

EMA starts contraceptive safety review

January 30, 2013 Manufacturing and Production, Sales and Marketing EMA, PRAC, VTE, contraception

Europe’s health regulator is to examine the safety of newer forms of contraceptive pills following concerns over potential health risks …
photo_charlie_richard

Oxyrane brings on board senior team

January 30, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Oxyrane, biotech

UK biotech firm Oxyrane has expanded to the US and made a number of senior appointments. The privately-owned Manchester-based company’s first …
Lonza image

Lonza says 2012 growth was solid, but more restructuring due

January 29, 2013 Manufacturing and Production Arch, CMO, Lonza

Swiss contract manufacturing organisation (CMO) and ingredients supplier Lonza posted a 46% increase in revenues to 3.93 billion francs last …
Synthon image

Synthon opens ADC plant in the Netherlands

January 29, 2013 Manufacturing and Production ADC, Synthon

Synthon Biopharmaceuticals says it has opened officially opened a new antibody-drug conjugate (ADC) manufacturing facility in Nijmegen, the Netherlands. The …
The Gateway to Local Adoption Series

Latest content